{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T04:33:21Z","timestamp":1793766801204,"version":"4.6.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Italian National Insurance Institute for Workplace Injuries"},{"name":"Umberto Veronesi Foundation"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.lungcan.2020.03.015","type":"journal-article","created":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T17:03:13Z","timestamp":1584637393000},"page":"73-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Favorable incremental cost-effectiveness ratio for lung cancer screening in Italy"],"prefix":"10.1016","volume":"143","author":[{"given":"Giulia","family":"Veronesi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2417-8589","authenticated-orcid":false,"given":"Niccol\u00f2","family":"Navone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Novellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9523-6651","authenticated-orcid":false,"given":"Elisa","family":"Dieci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Toschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Velutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Solinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Vanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Alloisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2335-7304","authenticated-orcid":false,"given":"Simone","family":"Ghislandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2020.03.015_bib0005","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1093\/annonc\/mdx033","article-title":"European cancer mortality predictions for the year 2017, with focus on lung cancer","author":"Malvezzi","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.lungcan.2020.03.015_bib0010","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1093\/eurheartj\/ehw334","article-title":"Cardiovascular disease in Europe: epidemiological update 2016","volume":"37","author":"Townsend","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.lungcan.2020.03.015_bib0015","unstructured":"www.registri-tumori.it\/PDF\/AIOM2017\/2017_numeri_del_cancro.pdf. Date last (Accessed: November 15 2018)."},{"key":"10.1016\/j.lungcan.2020.03.015_bib0020","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S1470-2045(13)70442-X","article-title":"Economic burden of cancer across the European Union: a population-based cost analysis","volume":"4","author":"Luengo-Fernandez","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lungcan.2020.03.015_bib0025","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening","volume":"365","author":"Aberle","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2020.03.015_bib0030","doi-asserted-by":"crossref","first-page":"330","DOI":"10.7326\/M13-2771","article-title":"Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement","volume":"160","author":"Moyer","year":"2014","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.lungcan.2020.03.015_bib0035","doi-asserted-by":"crossref","first-page":"412","DOI":"10.6004\/jnccn.2018.0020","article-title":"Lung cancer screening, version 3. 2018, NCCN clinical practice guidelines in oncology","volume":"16","author":"Wood","year":"2018","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.lungcan.2020.03.015_bib0040","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1377\/hlthaff.2011.0814","article-title":"An actuarial analysis shows that offering lung cancer screening as an insurance benefit would save lives at relatively low cost","volume":"31","author":"Pyenson","year":"2012","journal-title":"Health Aff. (Millwood)"},{"key":"10.1016\/j.lungcan.2020.03.015_bib0045","unstructured":"https:\/\/wclc2018.iaslc.org\/media\/2018%20WCLC%20Press%20Program%20Press%20Release%20De%20Koning%209.25%20FINAL%20.pdf Date last (Accessed: March 10 2018)."},{"issue":"9","key":"10.1016\/j.lungcan.2020.03.015_bib0050","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1136\/thoraxjnl-2016-209825","article-title":"The ITALUNG Working Group Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial","volume":"72","author":"Paci","year":"2017","journal-title":"Thorax"},{"key":"10.1016\/j.lungcan.2020.03.015_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta20400","article-title":"The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer","volume":"20","author":"Field","year":"2016","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.lungcan.2020.03.015_bib0060","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa1312547","article-title":"Cost-effectiveness of CT screening in the national lung screening trial","volume":"371","author":"Black","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2020.03.015_bib0065","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.lungcan.2018.07.036","article-title":"Cost-utility analysis of a potential lung cancer screening program for a high-risk population in Germany: a modelling approach","volume":"124","author":"Hofer","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2020.03.015_bib0070","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/RTI.0000000000000136","article-title":"Computed tomography screening for lung cancer in the national lung screening trial: a cost-effectiveness analysis","volume":"30","author":"Black","year":"2015","journal-title":"J. Thorac. Imaging"},{"key":"10.1016\/j.lungcan.2020.03.015_bib0075","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1097\/JTO.0000000000000283","article-title":"Resource utilization and costs during the initial years of lung cancer screening with computed tomography in Canada","volume":"9","author":"Cressman","year":"2014","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2020.03.015_bib0080","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jval.2013.05.007","article-title":"Cost-effectiveness of baseline low-dose computed tomography screening for lung cancer: the Israeli experience","volume":"16","author":"Shmueli","year":"2013","journal-title":"Value Health"},{"key":"10.1016\/j.lungcan.2020.03.015_bib0085","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/S0959-8049(01)00205-2","article-title":"Economic decision analysis model of screening for lung cancer","volume":"37","author":"Marshall","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.lungcan.2020.03.015_bib0090","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1001\/jama.289.18.2358-a","article-title":"Cost-effectiveness of screening for lung cancer","volume":"289","author":"Chirikos","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.lungcan.2020.03.015_bib0095","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1148\/radiol.2342032061","article-title":"Cost-effectiveness of whole-body CT screening","volume":"234","author":"Beinfeld","year":"2005","journal-title":"Radiology"},{"key":"10.1016\/j.lungcan.2020.03.015_bib0100","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.lungcan.2004.11.001","article-title":"Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting","volume":"48","author":"Manser","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2020.03.015_bib0105","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1097\/JTO.0b013e31822e59b3","article-title":"Cost-effectiveness of computed tomography screening for lung cancer in the United States","volume":"6","author":"McMahon","year":"2011","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2020.03.015_bib0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071379","article-title":"A cost-utility analysis of lung cancer screening and the additional benefits of incorporating smoking cessation interventions","volume":"8","author":"Villanti","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.lungcan.2020.03.015_bib0115","first-page":"272","article-title":"Offering lung cancer screening to high-risk medicare beneficiaries saves lives and is cost-effective: an actuarial analysis","volume":"7","author":"Pyenson","year":"2014","journal-title":"Am. Health Drug Benefits"},{"key":"10.1016\/j.lungcan.2020.03.015_bib0120","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s40258-016-0226-5","article-title":"Cost-effectiveness analyses of lung cancer screening strategies using low-dose computed tomography: a systematic review","volume":"14","author":"Raymakers","year":"2016","journal-title":"Appl. Health Econ. Health Policy"},{"key":"10.1016\/j.lungcan.2020.03.015_bib0125","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1158\/1940-6207.CAPR-11-0026","article-title":"Lung cancer risk prediction to select smokers for screening CT- a model based on the Italian COSMOS trial","volume":"4","author":"Maisonneuve","year":"2011","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.lungcan.2020.03.015_bib0130","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1097\/JTO.0000000000000678","article-title":"The International Association for the Study of Lung Cancer Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming 8th edition of the TNM classification for lung cancer","volume":"10","author":"Asamura","year":"2015","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2020.03.015_bib0135","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1097\/JTO.0000000000000200","article-title":"Diagnostic performance of low-dose computed tomography screening for lung cancer over five years","volume":"9","author":"Veronesi","year":"2014","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2020.03.015_bib0140","unstructured":"American Cancer Society. https:\/\/www.cancer.org Date last (Accessed: December 24, 2017)."},{"key":"10.1016\/j.lungcan.2020.03.015_bib0145","unstructured":"Italian National Institute of Statistics (ISTAT). http:\/\/demo.istat.it\/str2017\/index.html Date last (Accessed: December 15, 2018)."},{"key":"10.1016\/j.lungcan.2020.03.015_bib0150","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1378\/chest.124.2.614","article-title":"The cost-effectiveness of low-dose CT screening for lung cancer: preliminary results of baseline screening","volume":"124","author":"Wisnivesky","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.lungcan.2020.03.015_bib0155","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0002-9343(82)90786-0","article-title":"A convenient approximation of life expectancy (the \u201cDEALE\u201d). I. Validation of the method","volume":"73","author":"Beck","year":"1982","journal-title":"Am. J. Med."},{"key":"10.1016\/j.lungcan.2020.03.015_bib0160","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1200\/JCO.2000.18.18.3302","article-title":"Systematic overview of cost-utility assessments in oncology","volume":"18","author":"Earle","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2020.03.015_bib0165","doi-asserted-by":"crossref","first-page":"353","DOI":"10.5301\/tj.5000644","article-title":"Smoking in Italy in 2015\u20132016: prevalence, trends, roll-your-own cigarettes, and attitudes towards incoming regulations","volume":"103","author":"Lugo","year":"2017","journal-title":"Tumori"},{"key":"10.1016\/j.lungcan.2020.03.015_bib0170","series-title":"Guide to the Methods of Technology Appraisal","year":"2013"},{"key":"10.1016\/j.lungcan.2020.03.015_bib0175","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/jama.289.3.313","article-title":"Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis","volume":"289","author":"Mahadevia","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.lungcan.2020.03.015_bib0180","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000010461","article-title":"Lung cancer screening CT-based coronary artery calcification in predicting cardiovascular events. A systematic review and meta-analysis","volume":"97","author":"Fan","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.lungcan.2020.03.015_bib0185","article-title":"Assessment of lung cancer risk on the basis of a biomarker panel of circulating proteins","volume":"4","author":"Guida","year":"2018","journal-title":"JAMA Oncol."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500220303457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500220303457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:38:30Z","timestamp":1759235910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500220303457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":37,"alternative-id":["S0169500220303457"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2020.03.015","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Favorable incremental cost-effectiveness ratio for lung cancer screening in Italy","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2020.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}